Document is current

Any future updates will be listed below

Leveraging quantitative systems pharmacology modeling for elranatamab regimen optimization in relapsed or refractory multiple myeloma

Crossref DOI link: https://doi.org/10.1038/s41540-025-00585-z

Published Online: 2025-09-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark